Here are five takeaways:
1. The cleared indication expands the use of the Certex screws for use in the posterior cervical spine. It is now indicated for implantation using a posterior approach at the craniocervical junction, the cervical spine and the thoracic spine.
2. The system is intended to treat patients with advanced stage tumors involving the cervical spine.
3. The Certex Spinal Fixation System can be linked to the Fortex Pedicle Screw System and the Xpress Minimally Invasive Pedicle Screw System with rod-to-rod connectors and transition rods.
4. Xtant Medical recently reported its first quarter 2016 financial results. The company’s quarterly revenues hit $21 million, a 3 percent decrease from the same period in 2015.
5. Additionally, Xtant Medical received two Montana Department of Commerce grants totaling $155,000. The funds will help Bacterin International, a Xtant wholly-owned subsidiary, expand its orthobiologic process facility.
More articles on devices:
Misonix revenue reaches $5.4M in Q3: 8 highlights
RTI Surgical outlines why stockholders should elect its director nominees on WHITE proxy card: 5 points
Stryker, Smith & Nephew, K2M & more: 18 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
